Pacific Biosciences Of California | PACB - Operating Profit

Stock Price
1.39
Daily Change
0.01 0.72%
Monthly
-23.20%
Yearly
0%
Q1 Forecast
1.34

Pacific Biosciences Of California reported $-64.08M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Agilent USD 353M 90M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Danaher USD 1.5B 348M Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Illumina USD 256M 6M Dec/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Pacific Biosciences Of California USD -64.08M 111.77M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Standard Biotools USD -23.47M 230K Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 270.52M 78.4M Dec/2025